482 related articles for article (PubMed ID: 15083641)
1. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Hammarsten J; Högstedt B
Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
[TBL] [Abstract][Full Text] [Related]
2. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
3. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia.
Hammarsten J; Högstedt B
Blood Press; 1999; 8(1):29-36. PubMed ID: 10412880
[TBL] [Abstract][Full Text] [Related]
4. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
Hammarsten J; Högstedt B
Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
[TBL] [Abstract][Full Text] [Related]
5. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
Hammarsten J; Högstedt B
Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674
[TBL] [Abstract][Full Text] [Related]
6. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.
Hammarsten J; Högstedt B; Holthuis N; Mellström D
Prostate Cancer Prostatic Dis; 1998 Mar; 1(3):157-162. PubMed ID: 12496910
[TBL] [Abstract][Full Text] [Related]
7. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
[TBL] [Abstract][Full Text] [Related]
8. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
Park JS; Koo KC; Kim HK; Chung BH; Lee KS
Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome in patients with prostate cancer.
de Santana IA; Moura GS; Vieira NF; Cipolotti R
Sao Paulo Med J; 2008 Sep; 126(5):274-8. PubMed ID: 19099161
[TBL] [Abstract][Full Text] [Related]
10. Significant association of metabolic indices, lipid profile, and androgen levels with prostate cancer.
Tewari R; Chhabra M; Natu SM; Goel A; Dalela D; Goel MM; Rajender S
Asian Pac J Cancer Prev; 2014; 15(22):9841-6. PubMed ID: 25520115
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
12. Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men - a cross-sectional study.
Tewari R; Rajender S; Natu SM; Goel A; Dalela D; Goel MM; Tondon P
Cytokine; 2013 Aug; 63(2):130-4. PubMed ID: 23669251
[TBL] [Abstract][Full Text] [Related]
13. A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer.
Hammarsten J; Damber JE; Peeker R; Mellström D; Högstedt B
Cancer Epidemiol; 2010 Oct; 34(5):574-9. PubMed ID: 20702155
[TBL] [Abstract][Full Text] [Related]
14. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
15. Midlife metabolic factors and prostate cancer risk in later life.
Dickerman BA; Torfadottir JE; Valdimarsdottir UA; Wilson KM; Steingrimsdottir L; Aspelund T; Batista JL; Fall K; Giovannucci E; Sigurdardottir LG; Tryggvadottir L; Gudnason V; Markt SC; Mucci LA
Int J Cancer; 2018 Mar; 142(6):1166-1173. PubMed ID: 29114858
[TBL] [Abstract][Full Text] [Related]
16. Effects of components of metabolic syndrome on sexual function in Korean BPH/LUTS patients.
Lee SH; Kim JC; Lee JY; Kim JH; Oh CY; Lee SW; Yoo SJ; Chung BH
J Sex Med; 2009 Aug; 6(8):2292-8. PubMed ID: 19493291
[TBL] [Abstract][Full Text] [Related]
17. Impact of waist-hip-ratio and body-mass-index on hormonal and metabolic parameters in young, obese women.
Hollmann M; Runnebaum B; Gerhard I
Int J Obes Relat Metab Disord; 1997 Jun; 21(6):476-83. PubMed ID: 9192231
[TBL] [Abstract][Full Text] [Related]
18. Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men.
Zhang X; Zeng X; Liu Y; Dong L; Zhao X; Qu X
Urol Int; 2014; 93(2):214-9. PubMed ID: 24862628
[TBL] [Abstract][Full Text] [Related]
19. Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.
Yin Z; Yang JR; Rao JM; Song W; Zhou KQ
Asian J Androl; 2015; 17(5):826-30. PubMed ID: 25677137
[TBL] [Abstract][Full Text] [Related]
20. Hypertension, serum insulin, obesity and the metabolic syndrome.
Wannamethee SG; Shaper AG; Durrington PN; Perry IJ
J Hum Hypertens; 1998 Nov; 12(11):735-41. PubMed ID: 9844943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
